<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Source Sans Pro";}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-IN link=blue vlink="#954F72" style='word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal align=center style='text-align:center'><span
style='font-size:28.0pt;line-height:107%;color:#4472C4'>Predict your risk of
having diabetes!</span></p>

<p class=MsoNormal align=center style='text-align:center'><span
style='font-size:28.0pt;line-height:107%;color:#4472C4'>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center'><span
style='font-size:12.0pt;line-height:107%;font-family:"Calibri Light",sans-serif;
color:#31333F;background:white'>Studies have shown that a significant number of
people who are diabetic are unaware of their condition. Even developed
countries with high per capita expenditure on healthcare, like the US, have
around 8.5 million adults with undiagnosed diabetes. This represents nearly 23
percent of all US adults with diabetes. On a global scale, some papers claim
that 1 in 2 people living with diabetes don’t know that they have it.</span></p>

<p class=MsoNormal align=center style='text-align:center'><span
style='font-size:12.0pt;line-height:107%;font-family:"Calibri Light",sans-serif;
color:#31333F;background:white'>This lack of awareness can be very dangerous.
Uncontrolled diabetes mellitus may lead to many serious complications like the
ones shown below:</span></p>

<p class=MsoNormal><span style='font-size:12.0pt;line-height:107%;font-family:
"Calibri Light",sans-serif;color:#31333F;background:white'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:12.0pt;line-height:107%;font-family:
"Calibri Light",sans-serif;color:#31333F;background:white'>&nbsp;</span></p>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0 width=1512
 style='width:40.0cm;margin-left:28.05pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=917 valign=top style='width:687.5pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;text-indent:-18.0pt;line-height:normal'><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F'>1)<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F;
  background:white'>Diabetic retinopathy : The development and progression of
  DR is primarily caused by the tissue-damaging effects of chronic
  hyperglycaemia that results in a complex interplay of multiple mechanisms
  ,which cause two basic changes within the retinal vessels, namely: abnormal
  permeability, and occlusion with ischemia and subsequent neovascularization.</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
  line-height:normal'><span style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;
  color:#31333F;background:white'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
  line-height:normal'><span style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;
  color:#31333F;background:white'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
  line-height:normal'><span style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;
  color:#31333F;background:white'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
  line-height:normal'><span style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;
  color:#31333F;background:white'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
  line-height:normal'><span style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;
  color:#31333F;background:white'>&nbsp;</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
  line-height:normal'><span style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;
  color:#31333F;background:white'>&nbsp;</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F;
  background:white'>&nbsp;</span></p>
  </td>
  <td width=595 valign=top style='width:446.5pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
  line-height:normal'><span style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;
  color:#31333F;background:white'><img width=273 height=185 id="Picture 2"
  src="trial_files/image001.jpg"
  alt="Diabetic Retinopathy - Eye Care Surgery Center"></span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;text-align:center;
  line-height:normal'><span style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;
  color:#31333F;background:white'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=917 valign=top style='width:687.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;text-indent:-18.0pt;line-height:normal'><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F'>2)<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F;
  background:white'>Diabetic nephropathy : </span><span style='font-size:12.0pt;
  font-family:"Calibri Light",sans-serif;color:#232323;background:white'>Hyperglycaemia
  results in production of advanced glycation end-products (AGE) and reactive
  oxygen species. These aberrant metabolic products activate intercellular
  signaling for proinflammatory and profibrotic gene expression with production
  of a host of mediators for cellular injury.</span></p>
  </td>
  <td width=595 valign=top style='width:446.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:18.0pt;text-align:center;line-height:normal'><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif'><img
  width=309 height=231 id="Picture 3" src="trial_files/image002.jpg"
  alt="Pathology Outlines - Diabetic kidney disease"></span></p>
  </td>
 </tr>
 <tr>
  <td width=917 valign=top style='width:687.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;text-indent:-18.0pt;line-height:normal'><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F'>3)<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F;
  background:white'>Diabetic neuropathy : </span><span style='font-size:12.0pt;
  font-family:"Calibri Light",sans-serif;color:#232323;background:white'>In
  diabetes, a complex array of metabolic and vascular factors shift the balance
  between nerve fiber damage and nerve fiber repair in favor of damage [</span><a
  href="https://www.uptodate.com/contents/pathogenesis-of-diabetic-polyneuropathy/abstract/2"><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#005B92;
  background:white'>2</span></a><span style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;
  color:#232323;background:white'>]. This occurs in a fiber-selective pattern
  that preferentially affects the more vulnerable distal sensory and autonomic
  fibers, leading to the progressive loss of sensation that underlies the
  clinical manifestations of diabetic polyneuropathy.</span></p>
  </td>
  <td width=595 valign=top style='width:446.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:18.0pt;text-align:center;line-height:normal'><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif'><img
  border=0 width=319 height=192 id="Picture 4" src="trial_files/image003.jpg"
  alt="Combination treatment provides more pain relief than monotherapy in diabetic  neuropathy: Lancet"></span></p>
  </td>
 </tr>
 <tr>
  <td width=917 valign=top style='width:687.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;text-indent:-18.0pt;line-height:normal'><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F'>4)<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F;
  background:white'>Diabetic foot Ulcers : Chronic ulceration in patients with
  diabetes is multifactorial, due to a combination of diabetic neuropathy,
  autonomic dysfunction, and vascular insufficiency. Nonischemic diabetic foot
  ulcers are due to a combination of foot deformities and neuropathy preventing
  the sensation of pain in areas of the foot that are traumatized.</span></p>
  </td>
  <td width=595 valign=top style='width:446.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:18.0pt;text-align:center;line-height:normal'><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif'><img
  border=0 width=269 height=182 id="Picture 5" src="trial_files/image004.jpg"></span></p>
  </td>
 </tr>
 <tr>
  <td width=917 valign=top style='width:687.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;text-indent:-18.0pt;line-height:normal'><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F'>5)<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
  style='font-size:12.0pt;font-family:"Calibri Light",sans-serif;color:#31333F;
  background:white'>Macrovascular complications like stroke, coronary artery
  disease, peripheral vascular disease.</span></p>
  </td>
  <td width=595 valign=top style='width:446.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:18.0pt;text-align:center;line-height:normal'><img
  border=0 width=298 height=248 id="Picture 6" src="trial_files/image005.jpg"
  alt="Type 1 Diabetes Complications"></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=center style='text-align:center'><span
style='font-family:"Source Sans Pro",sans-serif;color:#31333F;background:white'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-family:"Source Sans Pro",sans-serif;
color:#31333F;background:white'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:28.0pt;line-height:107%;color:#4472C4'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-family:"Source Sans Pro",sans-serif;
color:#31333F;background:white'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-family:"Source Sans Pro",sans-serif;
color:#31333F;background:white'>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center'><span
style='font-size:28.0pt;line-height:107%;color:#4472C4'>&nbsp;</span></p>

<p class=MsoNormal align=center style='text-align:center'><span
style='font-size:28.0pt;line-height:107%;color:#4472C4'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-family:"Source Sans Pro",sans-serif;
color:#31333F;background:white'>The global prevalence of diabetes mellitus in
2019 was around 9.3% which is estimated to rise to 10.2% by 2030 and 10.9% by
2045. This future spike in diabetes can be attributed to a number of factors
including the rising standard of living in developing nations which is
generally associated with increased availability and consumption of processed
foods and transitioning to sedentary lifestyles.</span></p>

<p class=MsoNormal><span style='font-size:14.0pt;line-height:107%;color:#4472C4'>&nbsp;</span></p>

</div>

</body>

</html>
